Johnson & Johnson to Host Medical Devices and Diagnostics Business Review, Medical Devices and Diagnostics Business Review

Top Stories

»	Sensex, Nifty end near record highs as financials lead rally
»	26 e-commerce platforms declare compliance with self-audit to eliminate dark patterns: Govt
»	Gold edges lower on stronger dollar, Fed minutes weigh on rate-cut hopes
»	Financial inclusion, digital transformation are India’s big success stories: DFS Secretary
»	Goyal to visit Israel for high-level trade talks, proposed FTA review on agenda

PR Newswire | 26 May, 2010
NEW BRUNSWICK (New Jersey): Johnson & Johnson (NYSE: JNJ) will host a review of its Medical Devices & Diagnostics business for the investment community, beginning at 8:30 a.m. (Eastern Time) on June 3.

Alex Gorsky, Worldwide Chairman, Medical Devices & Diagnostics (MD&D) for Johnson & Johnson, will host the meeting at the Hyatt Regency Hotel in New Brunswick, N.J. He will be joined by senior leaders of MD&D's seven franchises: Cordis, DePuy, Diabetes Care, Ethicon, Ethicon Endo-Surgery, Ortho Clinical Diagnostics and Vision Care.

Investors and other interested parties may access the meeting by visiting the Johnson & Johnson website at www.investor.jnj.com for a simultaneous webcast of the presentation. A webcast and podcast replay will be available approximately two hours after the live webcast.

About Johnson & Johnson:
Caring for the world, one person at a time...inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 114,000 employees at more than 250 Johnson & Johnson companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.